However, in some ALL models, Mcl-1 may be not the unique determinant of ABT-737 resistance, since knockdown of protein expression by RNA interference does not result in significant changes of cytotoxicity [64]. This evidence concerns the gene MCL1 and acute lymphoblastic leukemia.